{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 7,
        "Importance": 6,
        "Impact": 5,
        "Duration": 4,
        "Virality": 3,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 2,
        "Tech_Mentions": 1
    },
    "Each_item": [
        {
            "News_content": "Dowling & Yahnke LLC Sells 87 Shares of Amgen, Inc. AMGN",
            "Correlation": 9,
            "Sentiment": 3,
            "Importance": 4,
            "Impact": 2,
            "Duration": 3,
            "Virality": 2,
            "Source_Score": 6,
            "Specificity": 9,
            "Sector_Spread": 1,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Amgen: A Biiotech Buy & Hold Story AMGN",
            "Correlation": 8,
            "Sentiment": 8,
            "Importance": 5,
            "Impact": 4,
            "Duration": 7,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 6,
            "Sector_Spread": 2,
            "Tech_Mentions": 1
        },
        {
            "News_content": "RBC AMGN Positive new incremental growth driver: Phase III \"Romo\" bone data shows high efficacy,suggests $1B+ franchise",
            "Correlation": 10,
            "Sentiment": 9,
            "Importance": 9,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 10,
            "Sector_Spread": 3,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Not sure what to do with AMGN? Explore our fundamental pros and cons",
            "Correlation": 7,
            "Sentiment": 5,
            "Importance": 3,
            "Impact": 2,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 5,
            "Specificity": 4,
            "Sector_Spread": 1,
            "Tech_Mentions": 1
        }
    ]
}